Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening
- Written by PR Newswire
![]() |
- Lunit's collaborative study supports AI as a viable alternative to one human reader in Europe's double reading system - published in The Lancet Digital Health
SEOUL, South Korea, Sept. 11, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is spearheading a...















